Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net loss	$ (701,454)	$ (621,813)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,897	4,980
Stock-based compensation expense	153,224	52,549
Changes in assets and liabilities:
Grant funds and other receivables	(38,463)	54,758
Prepaid expenses and other current assets	(30)	20,848
Accounts payable and accrued expenses	267,465	107,105
Total adjustments	384,093	240,240
Net cash used in operating activities	(317,361)	(381,573)
Cash flows from investing activities:
Purchase of property and equipment	(4,272)
Net cash used in investing activities	(4,272)
Cash flows from financing activities:
Net proceeds from sale of preferred stock	240,000	590,000
Proceeds from issuance of note payable		50,000
Principal repayment of note payable	(2,083)
Net cash provided by financing activities	237,917	640,000
Net increase (decrease) in cash and cash equivalents	(83,716)	258,427
Cash and cash equivalents at beginning of period	259,701	312,727
Cash and cash equivalents at end of period	$ 175,985	$ 571,154